AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32151482 — intervention group
Group type: EXPERIMENTAL
Intervention: EdgeFile (EF X3)
Number of subjects: 27
Study 33310432 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 U-Turn Test (5UTT) - smartphone-based assessment of U-turn speed, self-administered daily for 14 days
Number of subjects: 76
Study 33310432 — intervention group
Group type: COMPARATOR
Intervention: 5 U-Turn Test (5UTT) - smartphone-based assessment of U-turn speed
Number of subjects: 76
Study 35487730 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg daily
Number of subjects: 400
Study 35487730 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study 34956430 — intervention group
Group type: COMPARATOR
Intervention: Adductor Canal Block (ACB) only
Number of subjects: 60
Study 34956430 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Adductor Canal Block (ACB) and Popliteal Plexus Block (PPB)
Number of subjects: 60
Study 35999026 — intervention group
Group type: EXPERIMENTAL
Intervention: Marstacimab (300 mg, 150 mg, or 450 mg weekly doses based on inhibitor status)
Number of subjects: 26
Study 35999026 — intervention group
Group type: EXPERIMENTAL
Intervention: Marstacimab
Number of subjects: 26
Study 33148701 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib 15 mg once daily
Number of subjects: 1629
Study 33148701 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg every other week
Number of subjects: 1629
Study 33148701 — intervention group
Group type: COMPARATOR
Intervention: Switch to adalimumab
Number of subjects: 1629
Study 33148701 — intervention group
Group type: COMPARATOR
Intervention: Switch to upadacitinib
Number of subjects: 1629
Study 33148701 — intervention group
Group type: EXPERIMENTAL
Intervention: Rescued patients
Number of subjects: 1629
Study 33148701 — intervention group
Group type: COMPARATOR
Intervention: Both switch groups
Number of subjects: 1629
Study 32067100 — intervention group
Group type: EXPERIMENTAL
Intervention: Less invasive surfactant administration (LISA)
Number of subjects: 179
Study 32067100 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 179
Study 34182150 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide Oral Suspension (BOS) 2.0 mg twice daily
Number of subjects: 48
Study 34182150 — intervention group
Group type: COMPARATOR
Intervention: Placebo (BOS-PBO)
Number of subjects: 48
Study 34182150 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide Oral Suspension (BOS)
Number of subjects: 48
Study 33723979 — intervention group
Group type: EXPERIMENTAL
Intervention: Test toothpaste containing 0.454% SnF2, 0.072% sodium fluoride, and 5% sodium tripolyphosphate (n = 67)
Number of subjects: 135
Study 33723979 — intervention group
Group type: COMPARATOR
Intervention: Control toothpaste containing 0.76% sodium monofluorophosphate (n = 68)
Number of subjects: 135
Study 33723979 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Test and Control toothpastes
Number of subjects: 135
Study 35064574 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated coffee enriched with cocoa and fructo-oligosaccharides (FOS)
Number of subjects: 0
Study 35064574 — intervention group
Group type: EXPERIMENTAL
Intervention: Decaffeinated coffee enriched with cocoa and fructo-oligosaccharides (FOS)
Number of subjects: 0
Study 34363050 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure management (target systolic BP <120 mmHg)
Number of subjects: 7738
Study 34363050 — intervention group
Group type: COMPARATOR
Intervention: Standard blood pressure management (target systolic BP ≥120 mmHg)
Number of subjects: 7738
Study 33753445 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic low molecular weight heparin (LMWH)
Number of subjects: 0
Study 33332403 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness intervention
Number of subjects: 3
Study 33332403 — intervention group
Group type: COMPARATOR
Intervention: Active-control (music listening)
Number of subjects: 3
Study 34240659 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation at 4,000 IU/day for 6 weeks
Number of subjects: 24
Study 34240659 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 34752255 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric 3D toothbrush (Oral-B Pro-1000 with Oral-B Ortho head)
Number of subjects: 80
Study 34752255 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush (Oral-B Orthodontic brush)
Number of subjects: 80
Study 32106757 — intervention group
Group type: EXPERIMENTAL
Intervention: Gutbusters+Incentive
Number of subjects: 102
Study 32106757 — intervention group
Group type: COMPARATOR
Intervention: Gutbusters alone
Number of subjects: 102
Study 35627496 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised group physical exercise
Number of subjects: 282
Study 35627496 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 282
Study 35627496 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO-5 score ≤ 50
Number of subjects: 282
Study 35627496 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO-5 score > 50
Number of subjects: 282
Study 32557560 — intervention group
Group type: EXPERIMENTAL
Intervention: Spatial regression model with Gaussian random effects for the intervention arm.
Number of subjects: 0
Study 32557560 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthogonal regression to avoid spatial confounding.
Number of subjects: 0
Study 34913281 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant-rich dietary intervention (3 meal boxes daily for 4 weeks)
Number of subjects: 31
Study 34913281 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant-rich dietary intervention
Number of subjects: 31
Study 34913281 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual diet)
Number of subjects: 31
Study 34602400 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib combined with glucosamine hydrochloride therapy
Number of subjects: 128
Study 34602400 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib tablet therapy
Number of subjects: 128
Study 34446791 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback training (NFB) with theta/low-beta power ratio on EEG for 3 days
Number of subjects: 0
Study 34446791 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study 33202559 — intervention group
Group type: EXPERIMENTAL
Intervention: MET + TPT
Number of subjects: 60
Study 33202559 — intervention group
Group type: EXPERIMENTAL
Intervention: MET
Number of subjects: 60
Study 33202559 — intervention group
Group type: EXPERIMENTAL
Intervention: TPT
Number of subjects: 60
Study 36307989 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical gentamicin cream delivered via platform wound device (PWD)
Number of subjects: 0
Study 33694287 — intervention group
Group type: EXPERIMENTAL
Intervention: gshCBT
Number of subjects: 140
Study 33694287 — intervention group
Group type: EXPERIMENTAL
Intervention: gshBWL
Number of subjects: 140
Study 33694287 — intervention group
Group type: COMPARATOR
Intervention: CON
Number of subjects: 140
Study 32246899 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg of 4-fluoroamphetamine (4-FA)
Number of subjects: 12
Study 32246899 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg of 4-fluoroamphetamine (4-FA) in 150 mL Royal Club bitter lemon drink
Number of subjects: 12
Study 32246899 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 33237839 — intervention group
Group type: EXPERIMENTAL
Intervention: 25-Hydroxyvitamin D (25(OH)D) plasma levels
Number of subjects: 35
Study 33593885 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 108
Study 33593885 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 108
Study 35603416 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness intervention (audio-guided mindfulness exercise)
Number of subjects: 61
Study 35603416 — intervention group
Group type: COMPARATOR
Intervention: Control exercise
Number of subjects: 61
Study 35603416 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness intervention
Number of subjects: 61
Study 34217593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2524
Study 32036479 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation support for evidence-based physical health care
Number of subjects: 13
Study 32036479 — intervention group
Group type: EXPERIMENTAL
Intervention: Policies stating physical health care standards
Number of subjects: 13
Study 35768986 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ketamine
Number of subjects: 160
Study 35768986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 32585392 — intervention group
Group type: EXPERIMENTAL
Intervention: Turmeric and mefenamic acid (500 mg and 250 mg respectively)
Number of subjects: 128
Study 32585392 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefenamic acid (250 mg)
Number of subjects: 128
Study 32585392 — intervention group
Group type: EXPERIMENTAL
Intervention: Turmeric (500 mg)
Number of subjects: 128
Study 32585392 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 32585392 — intervention group
Group type: EXPERIMENTAL
Intervention: Turmeric and mefenamic acid combination
Number of subjects: 128
Study 35148511 — intervention group
Group type: EXPERIMENTAL
Intervention: aprotinin
Number of subjects: 90
Study 35148511 — intervention group
Group type: EXPERIMENTAL
Intervention: tranexamic acid (TXA)
Number of subjects: 90
Study 35148511 — intervention group
Group type: COMPARATOR
Intervention: no intervention (control)
Number of subjects: 90
Study 32538882 — intervention group
Group type: EXPERIMENTAL
Intervention: Walkbot locomotor training (WLT)
Number of subjects: 14
Study 32538882 — intervention group
Group type: COMPARATOR
Intervention: Conventional locomotor training (CLT)
Number of subjects: 14
Study 35266571 — intervention group
Group type: COMPARATOR
Intervention: TIPS alone (TIPS group)
Number of subjects: 56
Study 35266571 — intervention group
Group type: EXPERIMENTAL
Intervention: TIPS plus simultaneous SPSS embolization (TIPS+E group)
Number of subjects: 56
Study 36251574 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVACx6)
Number of subjects: 0
Study 36251574 — intervention group
Group type: COMPARATOR
Intervention: Four cycles of gemcitabine and cisplatin (GCx4)
Number of subjects: 0
Study 34000004 — intervention group
Group type: EXPERIMENTAL
Intervention: TriGuard™ HDH cerebral embolic deflection device (TG)
Number of subjects: 258
Study 34000004 — intervention group
Group type: COMPARATOR
Intervention: Control (no TG)
Number of subjects: 258
Study 34666014 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal radial access (DRA)
Number of subjects: 1300
Study 34666014 — intervention group
Group type: COMPARATOR
Intervention: Conventional transradial access (TRA)
Number of subjects: 1300
Study 34535086 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane (DES-group)
Number of subjects: 44
Study 34535086 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane (SEVO-group)
Number of subjects: 44
Study 32340502 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAS combined with diazepam
Number of subjects: 117
Study 32340502 — intervention group
Group type: COMPARATOR
Intervention: Sham TEAS combined with diazepam
Number of subjects: 117
Study 35820575 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma Center Trauma-Sensitive Yoga (TCTSY; n = 17)
Number of subjects: 41
Study 35820575 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Processing Therapy (CPT; n = 24)
Number of subjects: 41
Study 33978382 — intervention group
Group type: EXPERIMENTAL
Intervention: miR‐182 inhibitor
Number of subjects: 60
Study 33978382 — intervention group
Group type: EXPERIMENTAL
Intervention: miR‐182 mimics
Number of subjects: 60
Study 33978382 — intervention group
Group type: COMPARATOR
Intervention: miR‐182 expression levels
Number of subjects: 60
Study 33978382 — intervention group
Group type: COMPARATOR
Intervention: miR‐182 in plasma samples
Number of subjects: 60
Study 32762989 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite Time Trade-Off (cTTO)
Number of subjects: 1000
Study 32762989 — intervention group
Group type: EXPERIMENTAL
Intervention: Discrete Choice Experiment (DCE)
Number of subjects: 1000
Study 32762989 — intervention group
Group type: COMPARATOR
Intervention: DCE (N = 300)
Number of subjects: 1000
Study 32762989 — intervention group
Group type: EXPERIMENTAL
Intervention: DCE (N = 700)
Number of subjects: 1000
Study 34276440 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorcaserin
Number of subjects: 25
Study 34276440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 33826080 — intervention group
Group type: EXPERIMENTAL
Intervention: HLX02
Number of subjects: 649
Study 33826080 — intervention group
Group type: COMPARATOR
Intervention: EU-trastuzumab
Number of subjects: 649
Study 33038141 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 μg vaginal estrogen therapy (ET) for 52 weeks
Number of subjects: 205
Study 35998969 — intervention group
Group type: EXPERIMENTAL
Intervention: [68Ga]Ga-PentixaFor PET/CT
Number of subjects: 0
Study 35998969 — intervention group
Group type: COMPARATOR
Intervention: AVS
Number of subjects: 0
Study 32445952 — intervention group
Group type: COMPARATOR
Intervention: Improved Standard American Diet (iSAD)
Number of subjects: 17
Study 32445952 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Fat, High-Fiber Diet (LFD)
Number of subjects: 17
Study 32534646 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab, vemurafenib, and cobimetinib
Number of subjects: 514
Study 32534646 — intervention group
Group type: COMPARATOR
Intervention: Atezolizumab placebo, vemurafenib, and cobimetinib
Number of subjects: 514
Study 36130744 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy and stretching applied from the beginning of the appearance of the axillary cord, controlled and scheduled by the physiotherapist.
Number of subjects: 0
Study 36130744 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified what the control intervention is).
Number of subjects: 0
Study 33428709 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle (ILS)
Number of subjects: 2385
Study 33428709 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 2385
Study 33428709 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2385
Study 34528271 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision Aids (DAs) - one-page Option GridTM, four-page paper tool, 17-minute video, interactive website
Number of subjects: 21
Study 34528271 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision Aids (DAs)
Number of subjects: 21
Study 34528271 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 21
Study 35930199 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisectoral intervention (Shamba Maisha)
Number of subjects: 30
Study 32496814 — intervention group
Group type: EXPERIMENTAL
Intervention: NYU Caregiver Intervention (NYUCI) provided by ten Israeli clinicians (enhanced care)
Number of subjects: 100
Study 32496814 — intervention group
Group type: COMPARATOR
Intervention: Support group participation (usual care)
Number of subjects: 100
Study 32496566 — intervention group
Group type: EXPERIMENTAL
Intervention: Presession D-Cycloserine (DCS)
Number of subjects: 152
Study 32496566 — intervention group
Group type: EXPERIMENTAL
Intervention: Postsession D-Cycloserine (DCS)
Number of subjects: 152
Study 32496566 — intervention group
Group type: COMPARATOR
Intervention: Tailored D-Cycloserine (DCS)
Number of subjects: 152
Study 32496566 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study 34663135 — intervention group
Group type: EXPERIMENTAL
Intervention: Culture-sensitive Pain Neuroscience Education (CSPNE)
Number of subjects: 53
Study 34663135 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Pain Neuroscience Education (PNE)
Number of subjects: 53
Study 34663135 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study 32804266 — intervention group
Group type: EXPERIMENTAL
Intervention: Video feedback
Number of subjects: 51
Study 32804266 — intervention group
Group type: COMPARATOR
Intervention: Verbal feedback
Number of subjects: 51
Study 32804266 — intervention group
Group type: COMPARATOR
Intervention: Self-assessment
Number of subjects: 51
Study 36334128 — intervention group
Group type: COMPARATOR
Intervention: Sitting Only (SO)
Number of subjects: 15
Study 36334128 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting Plus Standing (SSt)
Number of subjects: 15
Study 36334128 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Plus Sitting (ES)
Number of subjects: 15
Study 36334128 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Plus Sitting Plus Standing (ESSt)
Number of subjects: 15
Study 32543021 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide (10 μg) administered three times daily for 26 weeks
Number of subjects: 108
Study 32543021 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered three times daily for 26 weeks
Number of subjects: 108
Study 35045736 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful Walking (MFW)
Number of subjects: 51
Study 35045736 — intervention group
Group type: COMPARATOR
Intervention: Moderate Walking (MW)
Number of subjects: 51
Study 34935709 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT, 3‐min intervals at 80% and 40% maximal O2, n = 20)
Number of subjects: 60
Study 34935709 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT, sustained 60% maximal O2, n = 20)
Number of subjects: 60
Study 34935709 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 60
Study 32369766 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training with peer support
Number of subjects: 51
Study 32369766 — intervention group
Group type: COMPARATOR
Intervention: Strength training alone
Number of subjects: 51
Study 36169043 — intervention group
Group type: EXPERIMENTAL
Intervention: Toric contact lenses
Number of subjects: 23
Study 36169043 — intervention group
Group type: COMPARATOR
Intervention: Spherical equivalent contact lenses
Number of subjects: 23
Study 33402377 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy Skills Scale
Number of subjects: 847
Study 34779220 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surgical aortic valve replacement (SAVR)
Number of subjects: 157
Study 34779220 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 157
Study 33472462 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-contact infrared thermometers (NCIT)
Number of subjects: 45
Study 33472462 — intervention group
Group type: COMPARATOR
Intervention: Infrared tympanic thermometers (ITT)
Number of subjects: 45
Study 33472462 — intervention group
Group type: COMPARATOR
Intervention: Mercury axillary thermometers (MAT)
Number of subjects: 45
Study 32433277 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced recovery pathway (17 evidence-based pre-, intra-, and postoperative care elements)
Number of subjects: 56
Study 32433277 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced recovery pathway
Number of subjects: 56
Study 32433277 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 56
Study 33740353 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoglobin A1c (HbA1c) levels in patients with FM
Number of subjects: 33
Study 33740353 — intervention group
Group type: EXPERIMENTAL
Intervention: QUICKI and HOMA‐IR indices in a subgroup of FM patients
Number of subjects: 33
Study 35820992 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based mindfulness training (SBMT)
Number of subjects: 8376
Study 35820992 — intervention group
Group type: COMPARATOR
Intervention: Teaching-as-usual (TAU)
Number of subjects: 8376
Study 34508694 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation (CBA)
Number of subjects: 218
Study 34508694 — intervention group
Group type: COMPARATOR
Intervention: Antiarrhythmic drugs (AAD)
Number of subjects: 218
Study 36000934 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifapentine/isoniazid (3HP)
Number of subjects: 896
Study 36000934 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin/isoniazid (3HR)
Number of subjects: 896
Study 36000934 — intervention group
Group type: COMPARATOR
Intervention: Isoniazid for 6 months
Number of subjects: 896
Study 36000934 — intervention group
Group type: COMPARATOR
Intervention: Isoniazid continuously
Number of subjects: 896
Study 36000934 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive treatment (8 rifamycin and 26 isoniazid monotherapy)
Number of subjects: 896
Study 33842907 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenite 200 μg
Number of subjects: 120
Study 33842907 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenite 50 μg
Number of subjects: 120
Study 33842907 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 36429439 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Group (HG) - 80% of maximal inspiratory pressure (MIP) for 6 weeks, 6 breaths a set, 4 sets a day, totaling 24 breaths a day.
Number of subjects: 30
Study 36429439 — intervention group
Group type: COMPARATOR
Intervention: Low-Intensity Group (LG) - 30% of maximal inspiratory pressure (MIP) for 6 weeks, 6 breaths a set, 4 sets a day, totaling 24 breaths a day.
Number of subjects: 30
Study 36429439 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - no intervention.
Number of subjects: 30
Study 33086370 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluation mode (participant observes and evaluates the team player)
Number of subjects: 120
Study 33086370 — intervention group
Group type: COMPARATOR
Intervention: Game play mode (participant is immersed as the leader)
Number of subjects: 120
Study 33086370 — intervention group
Group type: EXPERIMENTAL
Intervention: Both modes (evaluation and game play)
Number of subjects: 120
Study 32266197 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical massage and mental training combined
Number of subjects: 93
Study 32266197 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical massage
Number of subjects: 93
Study 32266197 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental training
Number of subjects: 93